Intermittent preventive treatment of infants with mefloquine reduces risk of clinical malaria in areas of moderate malaria transmission and high resistance to sulphadoxine-pyrimethamine, but safety and tolerability issues need consideration.

相似书籍

• Plasma and whole blood mefloquine concentrations during treatment of chloroquine-resistant falciparum malaria with the combination mefloquine-sulphadoxine-pyrimethamine.
  由: Karbwang, J, et al.
  出版: (1987)
• Qinghaosu, mefloquine, and pyrimethamine-sulfadoxine in falciparum malaria.
  由: Peto, T, et al.
  出版: (1985)
• Efficacy of Artesunate + Sulphadoxine-Pyrimethamine (AS + SP) and Amodiaquine + Sulphadoxine-Pyrimethamine (AQ + SP) for Uncomplicated falciparum Malaria in Equatorial Guinea (Central Africa)
  由: Pilar Charle, et al.
  出版: (2009-01-01)
• Determinants of the uptake of intermittent preventive treatment of malaria in pregnancy with sulphadoxine pyrimethamine in Sabatia Sub County, Western Kenya
  由: Mutanyi, JA, et al.
  出版: (2021)
• Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial.
  由: Shulman, C, et al.
  出版: (1999)